Skip to main content
. 2015 Dec 28;4(2):28–39.

Figure 3.

Figure 3

Pathway Enrichment of Higher Expression Genes in Non-Inflammatory Patients. A. The top 25 significant canonical pathways from the high expression genes in non-inflammatory patients. B. α-tocopherol (vitamin E) degradation. C. B-Cell development pathway with high expression genes in the non-inflammatory patients marked in purple. D. Serotonin degradation pathway. Highly expressed genes in inflammatory patients are marked in purple. E. Retinoate Biosynthesis I pathway. Highly expressed genes in inflammatory patients are marked in purple.